No profile data available.
Clene Inc. (CLNN) is a healthcare company in the nutritional and natural health products industry, based in Salt Lake City, United States, with about 76 full-time employees.
It reported revenue of $200,000 for fiscal year 2025, down 41.5% from fiscal year 2024, and net income of -$26.17 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $90,000, up 233.3% from a year before. Its market capitalization was $54.87 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
Clene reported $200,000 in revenue for fiscal year 2025, down 41.5% from $342,000 in fiscal year 2024. In Q2 2026 revenue was $90,000.
$54.87 million as of October 9, 2026.
Listed companies of a similar size in the same industry (nutritional and natural health products) include Niagen Bioscience, Inc. (NAGE), LifeVantage Corporation (LFVN), Goldenwell Biotech, Inc. (GWLL), Harvard Apparatus Regenerative Technology Inc. (HRGN).